✦ LIBER ✦

Combined therapy with Fludarabine and Cyclophosphamide in relapsed/resistant patients with B-cell chronic lymphocytic leukaemia and non-Hodgkin's lymphomas

✍ Scribed by Francesco Zaja; Adolfo Rogato; Domenico Russo; Luciana Marin; Federico Silvestri; Michele Baccarani Chair

Book ID: 114792335
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 194 KB
Volume: 59
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.1997.tb01694.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Low-dose oral fludarabine plus cyclophos

Low-dose oral fludarabine plus cyclophosphamide in elderly patients with untreated and relapsed or refractory chronic lymphocytic Leukaemia

✍ Francesco Forconi; Alberto Fabbri; Mariapia Lenoci; Elisa Sozzi; Alessandro Gozz 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB

## Abstract Fludarabine plus cyclophosphamide (FC) at conventional doses is an effective treatment for chronic lymphocytic leukaemia (CLL). However, FC at standard doses may give hematological and non‐hematological toxicity, predominantly in the elderly. Intravenous or oral low‐dose FC regimens rem

Fludarabine, cyclophosphamide, and ritux

Fludarabine, cyclophosphamide, and rituximab for the treatment of patients with chronic lymphocytic leukemia or indolent non-hodgkin lymphoma

✍ Constantine S. Tam; Max Wolf; H. Miles Prince; E. Henry Januszewicz; David Weste 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB 👁 1 views

Impaired B-lymphocyte reactivity in pati

Impaired B-lymphocyte reactivity in patients with Hodgkin's disease and non-Hodgkin-lymphomas

✍ R�hl, H. ;Enders, B. ;Bur, M. ;Sieber, G. 📂 Article 📅 1981 🏛 Springer-Verlag ⚖ 626 KB

Bcl-2 rearrangements with breakpoints in

Bcl-2 rearrangements with breakpoints in both vcr and mbr in non-Hodgkin’s lymphomas and chronic lymphocytic leukaemia

✍ Mats Merup; Tatjana Spasokoukotskaja; Stefan Einhorn; C. I. Edvard Smith; Gösta 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB

Phase I/II study of 2-chloro-2′-deoxyade

Phase I/II study of 2-chloro-2′-deoxyadenosine with cyclophosphamide in patients with pretreated B cell chronic lymphocytic leukemia and indolent non-Hodgkin’s lymphoma

✍ Van Den Neste, E; Louviaux, I; Michaux, J L; Delannoy, A; Michaux, L; Sonet, A; 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 100 KB

Paraneoplastic pemphigus in two patients

Paraneoplastic pemphigus in two patients with B-cell non-Hodgkin's lymphoma: Significant responses to cyclophosphamide and prednisolone

✍ Hertzberg, Mark S.; Schifter, Mark; Sullivan, John; Stapleton, Karen 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 2 views

To the Editor: Semenzato et al. proposed new criteria for large granular lymphocyte (LGL) leukemia because patients with low levels of GL were similar to those with levels greater than 2,000 GL/l [1]. LGL leukemia is a GL proliferative disease often accompanied by pure red cell aplasia (PRCA). T-cel